Milan, 4 August 2020 – LIFTT, the investment operating company founded by Fondazione Compagnia Di San Paolo and Politecnico di Torino, and Bioengineering Laboratories S.r.l. (“BEL”), a medical device company controlled by the Delta Med group and by the founder Francesco Greco, announce a strategic-financial partnership in the BioMed sector.
Read the news: LIFTT focuses on Dialybrid